isoagglutinin

WordNet

an antibody produced by one individual that causes agglutination of red blood cells in other individuals of the same species

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 免疫系の臨床検査評価 laboratory evaluation of the immune system
2. 予防接種に対する免疫応答の評価 assessing the immunologic response to vaccination
3. 腎移植におけるHLAとABOの感作および脱感作 hla and abo sensitization and desensitization in renal transplantation
4. 原発性の体液性免疫不全：概要 primary humoral immune deficiencies an overview
5. 選択的IgM欠損症 selective igm deficiency

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment.

Gerber S1, Gaida A2, Spiegl N3, Wymann S2, Antunes AM3, Menyawi IE2, Zurbriggen B4, Hubsch A5, Imboden M2.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.BioDrugs.2016 Sep 19. [Epub ahead of print]
BACKGROUND: Hemolysis, a rare but potentially serious complication of intravenous immunoglobulin (IVIG) therapy, is associated with the presence of antibodies to blood groups A and B (isoagglutinins) in the IVIG product. An immunoaffinity chromatography (IAC) step in the production process could dec
PMID 27646589

Comparison of Acute Kidney Injury between ABO-compatible and ABO-incompatible Living Donor Liver Transplantation: A Propensity Matching Analysis.

Jun IG1, Lee B1, Kim SO2, Shin WJ1, Bang JY1, Song JG3, Song GW4, Lee SG4, Hwang GS1.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.Liver Transpl.2016 Sep 6. doi: 10.1002/lt.24634. [Epub ahead of print]
The anti-CD20 monoclonal antibody rituximab has significantly decreased the prevalence of antibody-mediated rejection of ABO-incompatible living donor liver transplantation (ABOi LDLT). However, little is known about acute kidney injury (AKI) following ABOi LDLT. The aim of this study was to identif
PMID 27595780

Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation.

Bang JB1, Kim BW1, Kim YB1, Wang HJ1, Lee HY1, Sim J1, Kim T1, Lee KL1, Hu XG1, Mao W1.
World journal of gastroenterology.World J Gastroenterol.2016 Aug 14;22(30):6925-35. doi: 10.3748/wjg.v22.i30.6925.
AIM: To evaluate the risk factors for ischemic-type biliary lesion (ITBL) after ABO-incompatible (ABO-I) adult living donor liver transplantation (ALDLT).METHODS: Among 141 ALDLTs performed in our hospital between 2008 and 2014, 27 (19%) were ABO-I ALDLT and 114 were ABO-identical/compatible ALDLT.
PMID 27570428

Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation

Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation